Literature DB >> 786019

Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.

W T Chiang, P Y Wei, E R Alexander.   

Abstract

The sera from 176 patients with cervical cancer were examined by indirect immunofluorescence against cervical cancer cells (imprints of cervical cancer tissue). The mean serum titer in these patients was significantly higher than the titer in two control groups of identical size. These tumor-related antibodies were also higher in titer in sera from a small sample of nine husbands of cancer patients than in 18 control group patients. A cell-mediated immune response was studied with the use of leukocyte-migration inhibition from 39 blood specimens, including 23 patients with invasive epithelial carcinoma, five with intraepithelial carcinoma of the uterine cervix, six with other gynecologic diseases, and five without gynecologic disease. Migration inhibition was demonstrated for squamous cell carcinoma of the uterine cervix, suggesting a common specific cell-mediated response.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786019     DOI: 10.1016/0002-9378(76)90475-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Immunoglobulins and secretory component in endometrium and cervix. Influence of inflammation and carcinoma.

Authors:  J Hurlimann; R Dayal; E Gloor
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-03-10

Review 2.  Is screening for cervical cancer worthwhile?

Authors:  J F Murphy
Journal:  Ir J Med Sci       Date:  1980-08       Impact factor: 1.568

3.  Efficacy of screening for cervical cancer: a review.

Authors:  D S Guzick
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

4.  Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.

Authors:  J Tosner; B Fixa
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

5.  Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma.

Authors:  A W van de Linde; M Streefkerk; H J Schuurman; E R te Velde; L Kater
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.